CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank8
3Y CAGR-59.7%
5Y CAGR-41.9%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-59.7%/yr
vs -6.0%/yr prior
5Y CAGR
-41.9%/yr
Recent deceleration
Acceleration
-53.8pp
Decelerating
Percentile
P8
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $12.67M | -66.7% |
| 2024 | $38.05M | +121.6% |
| 2023 | $17.17M | -91.1% |
| 2022 | $193.65M | -5.8% |
| 2021 | $205.53M | +7.1% |
| 2020 | $191.86M | +1.8% |
| 2019 | $188.43M | -23.9% |
| 2018 | $247.58M | +39.4% |
| 2017 | $177.55M | +69.7% |
| 2016 | $104.64M | - |